Siranalen 75 mg tvrde kapsule
| Name | Siranalen 75 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-398910392 |
| Active Substance | pregabalin |
| Composition | jedna tvrda kapsula sadrži 75 mg pregabalina |
| Pharmaceutical Form | kapsula, tvrda |
| Packaging [MA Number for Packaging] | 14 kapsula u blisteru, u kutiji [HR-H-398910392-01] 21 kapsula u blisteru, u kutiji [HR-H-398910392-02] 30 kapsula u blisteru, u kutiji [HR-H-398910392-03] 56 kapsula u blisteru, u kutiji [HR-H-398910392-04] 84 kapsule u blisteru, u kutiji [HR-H-398910392-05] 100 kapsula u blisteru, u kutiji [HR-H-398910392-06] 112 kapsula u blisteru, u kutiji [HR-H-398910392-07] |
| Manufacturer | Medochemie Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar |
| Marketing Authorisation Date | 19.10.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/20-02/92 |
| Registration Number | 381-12-01/154-20-04 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N02BF02 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
